The stock market performance of Centessa Pharmaceuticals plc ADR has been very steady. Over the last year, the company’s stock hit its highest at $18.74 on 11/13/24, while the lowest price during the same time frame was $5.58, recorded on 12/01/23.
52-week price history of CNTA Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Centessa Pharmaceuticals plc ADR’s current trading price is -2.93% away from its 52-week high, while its distance from the 52-week low is 225.81%. The stock’s price range during this period has fluctuated between $5.58 and $18.74. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.63 million for the day, which was evidently lower than the average daily volume of 0.65 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Centessa Pharmaceuticals plc ADR (CNTA) has experienced a quarterly rise of 41.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.39B and boasts a workforce of 76 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 13.79, with a change in price of +9.42. Similarly, Centessa Pharmaceuticals plc ADR recorded 534,874 in trading volume during the last 100 days, posting a change of +107.41%.
CNTA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CNTA stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.17.
CNTA Stock Stochastic Average
The raw stochastic average for Centessa Pharmaceuticals plc ADR over the last 50 days is presently at 87.09%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 87.09%. Further, the company’s Stochastic %K and %D values for the last 20 days were 65.10% and 52.27%, respectively.
CNTA Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded an increase of 128.52%. However, over the last six months, the performance has been weaker by 117.84%. The price of CNTA increased 20.07% over the last 30 days. And in the last five days, it has surged by 3.94%.
